Bortezomib (CAS Number: 179324-69-7)

Product Description

Bortezomib (CAS Number: 179324-69-7)
Bortezomib is a therapeutic proteosome inhibitor used to treat people with multiple myeloma, a cancer of the bone marrow. Bortezomib is also used to treat people with mantle cell lymphoma, a fast-growing cancer that affects the immune system). It acts by killing the cancer cells. Anxiety, back pain, numbness, rash, itching are some of the side effects of this dhenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-; Boronic acid, [1-[[1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl) amino]propyl]amino]-3-methylbutyrug.

• Chemical formula: C₁₉H₂₅BN₄O₄
  
• Synonyms:Pyz-Phe-boroLeu;Boronic acid, [(1(R)-3-methyl-1-[[(2S)-1-oxo-3-pl]-, L-(S)-;[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid;PS 341
  
• Molecular weight:384.24
  
• Melting Point: 122-124°C    
  
• Assay  : 99 %
  
• Boiling Point:   684.30°C at 760 mm Hg
  
• Appearance: White or almost white powder          
  
• Packaging: 10/100g / bag